Teva Pharmaceutical's Sales Slump 18% - WSJ
Analysts have given Teva Pharmaceutical Industries Limited (NYSE:TEVA) an average recommendation of "Hold." - Best Stocks
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Stock Is Rising on Reports of an Opioid Settlement | Barron's
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
teva News and latest stories | The Jerusalem Post
Teva x Sankuanz Team Up for Hurricane Sandal at Opening Ceremony – Footwear News
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio? | Entrepreneur
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva Stock Soars After Reaching $4.25 Billion Opioid Settlement | Barron's
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Allergan on $40.5 Billion Drug Deal - The New York Times
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Teva CEO Schultz likely won't renew employment contract: reports
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
